Anna Sjögren

Direttore Tecnico/Scientifico/R&S presso EGETIS THERAPEUTICS AB

56 anni

Health Technology

Consumer Services

Posizioni attive di Anna Sjögren

Società	Posizione	Inizio	Fine
EGETIS THERAPEUTICS AB	Direttore Tecnico/Scientifico/R&S	-	-

Società	Posizione	Inizio	Fine
OxThera AB OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.	Corporate Officer/Principal	01/01/2013	01/12/2017

University of Uppsala	Undergraduate Degree
Karolinska Institutet	Undergraduate Degree

Distribuzione geografica

Svezia

Posizioni

Undergraduate Degree	2
Chief Tech/Sci/R&D Officer	1
Corporate Officer/Principal	1

Settori

Health Technology	3
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
EGETIS THERAPEUTICS AB	Health Technology

Aziende private	1
OxThera AB OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.	Health Technology

Aziende private

Health Technology